NORD MEXC RealStocks
Own real NORD shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1

Last updated: 2026-11-12 13:37:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Nordicus Partners Corporation (NORD) operates in the SERVICES-MANAGEMENT CONSULTING SERVICES sector and is listed on NASDAQ. The stock is currently priced at $3.00, with a market capitalization of $57.34M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.48 to $5.15. This page covers its latest market performance, valuation, price trends and company information.
$57.34M | |
$2.92 | |
$3.02 | |
$2.92 | |
$2.99 | |
33.00 | |
7.54K | |
-- | |
$5.15 | |
$1.48 | |
-- | |
-- |
Nordicus Partners Corporation (NORD) is trading at $3.00 in pre-market trading as of 2026-11-12 12:10:00, up 0.37% ($0.01) from the previous close of $2.99
Pre-market trading shows how investors are pricing NORD before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Nordicus Partners Corporation (NORD) moved from $4.10 to $3.00, representing a decline of 26.81% ($1.10).
The stock traded between $2.87 and $4.38 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 12.53 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 41.4%
NORD is currently trading at $3.00, placing it 41.4% of the way from its 52-week low of $1.48 to its 52-week high of $5.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
| Industry | SERVICES-MANAGEMENT CONSULTING SERVICES |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Nordicus Partners Corporation.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Nordicus Partners Corporation (NORD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NORD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NORD shares and USD.
NORD Shares to USD
1.00 NORD shares = 3.001 USD
Calculations are estimates based on the latest available price and are for reference only.